한국지질동맥경화학회 학술대회

While TG have historically been overshadowed by the focus on LDL-C, the cumulative evidence suggests that they should not be ignored as a risk factor for CVD and should clearly be taken into account when assessing atherosclerotic residual risk. TG and their remnant cholesterol have direct implications in the pathogenesis of atherosclerotic CVD and their management could represent an additional therapeutic strategy. In this session, we will present the relationship of remnant cholesterol and ASCVD, furthermore sarcopenia. Although lack of clear evidence, recent strategy to target remnant cholesterol will be introduced. Through this session, we hope you to widen the scope of lipid management.

Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality worldwide, yet many nontraditional risk factors are still underrecognized. This session highlights emerging contributors to ASCVD, offering new perspectives on disease development and progression. The first presentation explores how environmental pollution affects atherosclerosis through various biological mechanisms. The second addresses the impact of health inequity and social determinants on ASCVD risk. The final talk focuses on psychiatric disorders as an often-overlooked but important risk factor for ASCVD. By highlighting these topics, we aim to encourage a more comprehensive approach to ASCVD prevention.

Sex and gender differences in cardiometabolic health have emerged as a critical dimension in precision medicine. This symposium will explore these complexities, ranging from biological and hormonal mechanisms to gender-informed differences in diagnosis and therapy. Professor Erin D. Michos from Johns Hopkins University, USA, will discuss mechanistic insights linking sex and cardiometabolic risk. Professor Ji Eun Lee from Korea University, Republic of Korea, will highlight how sex and gender influence cardiovascular risk assessment and biomarker interpretation. Finally, Professor Hyun Ju Yoon from Chonnam National University, Republic of Korea, will address the differential responses of men and women to cardiometabolic therapies. This session aims to highlight why sex-specific approaches are essential for accurate risk stratification and effective treatment in cardiometabolic disease.